Sweden · Delayed Price · Currency is SEK Meds Apotek AB Statistics
Total Valuation
Meds Apotek AB has a market cap or net worth of SEK 460.59 million. The enterprise value is 396.31 million.
| Market Cap | 460.59M |
| Enterprise Value | 396.31M |
Important Dates
The last earnings date was Tuesday, July 21, 2026.
| Earnings Date | Jul 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Meds Apotek AB has 18.57 million shares outstanding. The number of shares has increased by 8.48% in one year.
| Current Share Class | 18.57M |
| Shares Outstanding | 18.57M |
| Shares Change (YoY) | +8.48% |
| Shares Change (QoQ) | -4.49% |
| Owned by Insiders (%) | 13.10% |
| Owned by Institutions (%) | 25.23% |
| Float | 15.00M |
Valuation Ratios
The trailing PE ratio is 30.80 and the forward PE ratio is 14.87.
| PE Ratio | 30.80 |
| Forward PE | 14.87 |
| PS Ratio | 0.43 |
| PB Ratio | 3.31 |
| P/TBV Ratio | 3.62 |
| P/FCF Ratio | 55.94 |
| P/OCF Ratio | 33.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.21, with an EV/FCF ratio of 48.13.
| EV / Earnings | 26.49 |
| EV / Sales | 0.37 |
| EV / EBITDA | 85.21 |
| EV / EBIT | 85.21 |
| EV / FCF | 48.13 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.75 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.29 |
| Interest Coverage | 8.91 |
Financial Efficiency
Return on equity (ROE) is 14.75% and return on invested capital (ROIC) is 2.68%.
| Return on Equity (ROE) | 14.75% |
| Return on Assets (ROA) | 1.24% |
| Return on Invested Capital (ROIC) | 2.68% |
| Return on Capital Employed (ROCE) | 3.29% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 22.04M |
| Profits Per Employee | 305,367 |
| Employee Count | 49 |
| Asset Turnover | 4.61 |
| Inventory Turnover | 7.10 |
Taxes
| Income Tax | -10.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 21.93 |
| 200-Day Moving Average | 37.04 |
| Relative Strength Index (RSI) | 67.36 |
| Average Volume (20 Days) | 30,625 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Meds Apotek AB had revenue of SEK 1.08 billion and earned 14.96 million in profits. Earnings per share was 0.81.
| Revenue | 1.08B |
| Gross Profit | 242.55M |
| Operating Income | 4.65M |
| Pretax Income | 4.67M |
| Net Income | 14.96M |
| EBITDA | 4.65M |
| EBIT | 4.65M |
| Earnings Per Share (EPS) | 0.81 |
Balance Sheet
The company has 66.66 million in cash and 2.38 million in debt, with a net cash position of 64.28 million or 3.46 per share.
| Cash & Cash Equivalents | 66.66M |
| Total Debt | 2.38M |
| Net Cash | 64.28M |
| Net Cash Per Share | 3.46 |
| Equity (Book Value) | 139.31M |
| Book Value Per Share | 7.50 |
| Working Capital | 100.39M |
Cash Flow
In the last 12 months, operating cash flow was 13.56 million and capital expenditures -5.33 million, giving a free cash flow of 8.23 million.
| Operating Cash Flow | 13.56M |
| Capital Expenditures | -5.33M |
| Depreciation & Amortization | 1.96M |
| Net Borrowing | -9.17M |
| Free Cash Flow | 8.23M |
| FCF Per Share | 0.44 |
Margins
Gross margin is 22.46%, with operating and profit margins of 0.43% and 1.39%.
| Gross Margin | 22.46% |
| Operating Margin | 0.43% |
| Pretax Margin | 0.43% |
| Profit Margin | 1.39% |
| EBITDA Margin | 0.43% |
| EBIT Margin | 0.43% |
| FCF Margin | 0.76% |
Dividends & Yields
Meds Apotek AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.48% |
| Shareholder Yield | -8.48% |
| Earnings Yield | 3.25% |
| FCF Yield | 1.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Meds Apotek AB is 44.50, which is 79.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 44.50 |
| Price Target Difference | 79.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 15.06% |
| EPS Growth Forecast (3Y) | 51.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Meds Apotek AB has an Altman Z-Score of 5.26 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.26 |
| Piotroski F-Score | 4 |